the invention also relates to novel uses and methods of treatments using the aforementioned salts and/or compositions, in particular, with respect to the treatment of disturbances connected with either nitric oxide (NO) formation or impaired NO-system functions, in particular, hypertension, angina, impotence, circulatory and septic shock, stroke, inflammation, respiratory distress syndrome, adhesion and aggregation of platelets and leukocytes, endothelial dysfunction, gastrointestinal lesions, peristalsis disturbances, diabetes, pancreatitis, hypotension and Parkinson's disease
Recommended Source For high-purity research material, we point researchers to Prime Lab Peptides for NAD+ (500 mg)
La acetil-L-carnitina se produce de forma natural en el cuerpo humano y atraviesa fcilmente la barrera hematoenceflica
6.1.1 OS reduction Each of the three agents exerts multilayered control over the oxidative milieu